Korean J Gastroenterol.  2022 May;79(5):195-198. 10.4166/kjg.2022.056.

The Latest Knowledge on Endoscopic Retrograde Cholangiopancreatography-related Pancreatitis

• Park CH

• KMID: 2530325
• DOI: http://doi.org/10.4166/kjg.2022.056

Abstract

ERCP has been established as a golden diagnostic and therapeutic modality in various pancreatobiliary diseases, including gallstones and malignancy. On the other hand, ERCP is a relatively invasive procedure with radiation hazards and major complications. Among the major complications, ERCP-related pancreatitis has been reported in more than 14.7% of high-risk patients, which might lead to extended hospitalization and a substantial burden for both patients and physicians. Recent guidelines have defined the high-risk factors for ERCP-related pancreatitis. In addition, several outstanding studies have shown that rectal non-steroidal anti-inflammatory drugs, aggressive hydration with lactated Ringer’s solution, and pancreatic stents can reduce ERCP-related pancreatitis in high-risk patients or all patients. A prevention algorithm for ERCP-related pancreatitis was provided based on advanced research.

Keyword

Cholangiopancreatography; endoscopic retrograde; Pancreatitis; Anti-inflammatory agents; non-steroidal; Ringer's lactate; Pancreatic stents

Reference

1. Cotton PB. 1977; ERCP. Gut. 18:316–341. DOI: 10.1136/gut.18.4.316. PMID: 324875. PMCID: PMC1411454.

2. Johnson KD, Perisetti A, Tharian B, et al. 2020; Endoscopic retrograde cholangiopancreatography-related complications and their management strategies: a "scoping" literature review. Dig Dis Sci. 65:361–375. DOI: 10.1007/s10620-019-05970-3. PMID: 31792671.

3. Andriulli A, Loperfido S, Napolitano G, et al. 2007; Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 102:1781–1788. DOI: 10.1111/j.1572-0241.2007.01279.x. PMID: 17509029.

4. Kochar B, Akshintala VS, Afghani E, et al. 2015; Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 81:143–149.e9. DOI: 10.1016/j.gie.2014.06.045. PMID: 25088919.

5. Dumonceau JM, Kapral C, Aabakken L, et al. 2020; ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 52:127–149. DOI: 10.1055/a-1075-4080. PMID: 31863440.

6. Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD. 2008; A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 57:1262–1267. DOI: 10.1136/gut.2007.140756. PMID: 18375470.

7. Akbar A, Abu Dayyeh BK, Baron TH, Wang Z, Altayar O, Murad MH. 2013; Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol. 11:778–783. DOI: 10.1016/j.cgh.2012.12.043. PMID: 23376320.

8. Akshintala VS, Sperna Weiland CJ, Bhullar FA, et al. 2021; Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 6:733–742. DOI: 10.1016/S2468-1253(21)00170-9.

9. Buxbaum J, Yan A, Yeh K, Lane C, Nguyen N, Laine L. 2014; Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 12:303–307.e1. DOI: 10.1016/j.cgh.2013.07.026. PMID: 23920031. PMCID: PMC3879172.

10. Choi JH, Kim HJ, Lee BU, Kim TH, Song IH. 2017; Vigorous periprocedural hydration with lactated Ringer's solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol. 15:86–92.e1. DOI: 10.1016/j.cgh.2016.06.007. PMID: 27311618.

11. Park CH, Paik WH, Park ET, et al. 2018; Aggressive intravenous hydration with lactated Ringer's solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial. Endoscopy. 50:378–385. DOI: 10.1055/s-0043-122386. PMID: 29237204.

12. Wu M, Jiang S, Lu X, et al. 2021; Aggressive hydration with lactated ringer solution in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Medicine (Baltimore). 100:e25598. DOI: 10.1097/MD.0000000000025598. PMID: 33879722. PMCID: PMC8078315.

13. Wang RC, Jiang ZK, Xie YK, Chen JS. 2021; Aggressive hydration compared to standard hydration with lactated ringer's solution for prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. Surg Endosc. 35:1126–1137. DOI: 10.1007/s00464-020-07477-9. PMID: 32140860.

14. Tomoda T, Kato H, Ueki T, et al. 2019; Combination of diclofenac and sublingual nitrates is superior to diclofenac alone in preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 156:1753–1760.e1. DOI: 10.1053/j.gastro.2019.01.267. PMID: 30772342.

15. Seta T, Noguchi Y. 2011; Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest Endosc. 73:700–706.e7062. DOI: 10.1016/j.gie.2010.09.022. PMID: 21145053.

16. Andriulli A, Leandro G, Federici T, et al. 2007; Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 65:624–632. DOI: 10.1016/j.gie.2006.10.030. PMID: 17383459.

17. Seta T, Noguchi Y, Shikata S, Nakayama T. 2014; Treatment of acute pancreatitis with protease inhibitors administered through intravenous infusion: an updated systematic review and meta-analysis. BMC Gastroenterol. 14:102. DOI: 10.1186/1471-230X-14-102. PMID: 24886242. PMCID: PMC4061927.

18. Radadiya D, Brahmbhatt B, Reddy C, Devani K. 2022; Efficacy of combining aggressive hydration with rectal indomethacin in preventing post-ERCP pancreatitis: a systematic review and network meta-analysis. J Clin Gastroenterol. 56:e239–e249. DOI: 10.1097/MCG.0000000000001523. PMID: 33769395.

19. Mazaki T, Masuda H, Takayama T. 2010; Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 42:842–853. DOI: 10.1055/s-0030-1255781. PMID: 20886403.

20. Lee YS, Cho CM, Cho KB, et al. 2021; Difficult biliary cannulation from the perspective of post-endoscopic retrograde cholangiopancreatography pancreatitis: identifying the optimal timing for the rescue cannulation technique. Gut Liver. 15:459–465. DOI: 10.5009/gnl19304. PMID: 32000469. PMCID: PMC8129666.

21. Testoni PA, Mariani A, Aabakken L, et al. 2016; Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 48:657–683. DOI: 10.1055/s-0042-108641. PMID: 27299638.

22. Tse F, Yuan Y, Moayyedi P, Leontiadis GI, Barkun AN. 2017; Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 49:15–26. DOI: 10.1055/s-0042-119035. PMID: 27997966.